Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel(University of Verona), Vincenzo Bronte(University of Verona)
Cited by 554
Related Papers
Altered macrophage differentiation and immune dysfunction in tumor development
|Journal of Clinical Investigation|2007|1.2k
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
|Cell Research|2019|246
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
|Journal for ImmunoTherapy of Cancer|2017|239
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
|Journal for ImmunoTherapy of Cancer|2019|187